Metabolism of metronidazole and antipyrine in hepatocytes isolated from mouse and rat
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 20 (2) , 185-191
- https://doi.org/10.3109/00498259009047154
Abstract
1. In order to study species-related differences and select a model for the human metabolism of metronidazole and antipyrine, the Michaëlis-Menten kinetics of metabolite formation from the two compounds were investigated in freshly isolated mouse and rat hepatocytes. 2. The average Km values for the formation of the major metronidazole metabolites ranged from 0.6 to 3 mM. The intrinsic clearance values (Vmax/Km) of metronidazole to the acetic acid, hydroxy and glucuronide metabolites were 58 (36-125) and 21 (12-28; PPP6 hepatocytes, for mouse and rat, respectively (median with range, n=6). 3. The average Km values for the formation of antipyrine metabolites ranged from 2 to 10mM. The intrinsic clearance values for production of 3-hydroxymethyl-, nor- and 4-hydroxyantipyrine were 232 (43-519) and 487 (296-793; PP0.05)nl/min per 106 hepatocytes, for mouse and rat, respectively (median with range, n=6). 4. The results demonstrate that metronidazole and antipyrine are metabolized with quantitative, but not qualitative, differences in isolated hepatocytes from mice and rats. Neither species provided an ideal model for the human metabolism of the two compounds.This publication has 18 references indexed in Scilit:
- Metabolism of metronidazole and antipyrine in isolated rat hepatocytesBiochemical Pharmacology, 1989
- Antipyrine metabolism in cultured rat hepatocytesBiochemical Pharmacology, 1987
- Inhibition and induction of metronidazole and antipyrine metabolismEuropean Journal of Clinical Pharmacology, 1987
- 1H nuclear magnetic resonance study of metronidazole metabolism by perfused rat liverEuropean Journal of Drug Metabolism and Pharmacokinetics, 1985
- Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation.Journal of Clinical Investigation, 1983
- Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrinein vitroby microsomal fractions of rat liverXenobiotica, 1982
- HPLC Determination of Antipyrine MetabolitesPharmacology, 1981
- Antipyrine metabolism in the rat by three hepatic monooxygenasesLife Sciences, 1980
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Biliary and renal excretion, hepatic metabolism, and hepatic subcellular distribution of metronidazole in the ratBiochemical Pharmacology, 1978